H ospital-performance metrics are increasingly used for value-based purchasing and public reporting. For example, Section 3001 of the Patient Protection and Affordable Care Act mandates incentive payments to hospitals that meet quality performance standards, which remain unspecified.
In 2008, the Massachusetts Health Care Quality and Cost Council 1 directed the Division of Health Care Finance and Policy (DHCFP) to study various approaches to estimating hospital-wide mortality rates as performance metrics. Medicare released hospital-wide mortality rates for its beneficiaries beginning in 1986 but suspended publication of the rates in 1993 because of methodologic concerns. 2, 3 The United Kingdom, various European countries, and Canada currently publish variants of such metrics, but questions remain regarding their clinical rationale, their usefulness for informing consumers and practitioners, and statistical methods for calculating them. [4] [5] [6] In response to the council's mandate, the DHCFP initiated systematic evaluations of various methods for calculating hospital-wide mortality rates. 7 At the DHCFP's request, we studied four such commercial methods.
Me thods

Study Design
In November 2008, the DHCFP issued a public call for methods to calculate risk-adjusted, hospital-wide mortality rates with the use of data from standard hospital discharge abstracts. Five commercial vendors responded, and two elected to develop a joint method, resulting in four methods for inclusion in this study. These four vendors are 3M Health Information Systems (3M), 8 which used a patient-classification system called All Patient Refined Diagnosis Related Groups; the Dr. Foster Unit at Imperial College London (Dr. Foster) 9 ; Thomson Reuters 8 ; and University HealthSystem Consortium (UHC)-Premier (the last representing the joint work of two of the vendors). 8 Each vendor specified its own methodologic approach. (Details are provided in the Supplementary Appendix, available with the full text of this article at NEJM.org.)
The DHCFP sent each vendor identical computerized files representing all discharges from Massachusetts general acute care hospitals from October 1, 2004, through September 30, 2007 (fiscal years 2005 through 2007). These data included demographic information, admission source and type, up to 15 discharge diagnoses and 15 procedure codes, and indicators of vital status (alive or dead) at discharge. We did not provide vendors with data on previous or subsequent hospitalizations, nor did we provide any information on outcomes after discharge, such as 30-day mortality. We asked vendors to apply their risk-adjustment algorithms to these data and provide the results of these analyses, including the predicted probability of in-hospital death for each individual discharge and hospital-level estimates (e.g., observed and expected mortality rates) for each hospital.
comparative Analyses
We performed three principal analyses of the four methods. First, each method used different inclusion and exclusion criteria in their mortality algorithms. We therefore calculated numbers of discharges and hospitals that were included by each method according to fiscal year and the overall 3-year period. For each method and for Massachusetts overall, we compared the attributes of discharges and hospitals, including in-hospital mortality rates; the age, sex, and race or ethnic group of patients; distributions of major diagnostic categories; and the mean length of stay and median number of discharges.
Second, we calculated Pearson correlation coefficients for individual discharge-level predicted probabilities of in-hospital death between pairs of methods. We performed the calculation in two ways: first using the set of discharges common to all four methods and then using discharges common to each pair of methods.
Third, because the goal of each method was to provide a measure of hospital quality, we examined how well hospital-specific performance estimates agreed among methods. For each method, we used the predicted and actual mortality rates that were based on the discharges included by that risk-adjustment method. Some methods produced risk-standardized mortality ratios, whereas others produced risk-standardized mortality rates. We converted all measures to ratios, multiplied these values by 100, and then examined pairwise correlations of ratios between methods, using Pearson correlation coefficients. We estimated three correlations: one with no weighting, one weighted by the smaller number of hospital discharges analyzed by any two methods, and one weighted by the larger number of discharges analyzed by any two methods. To quantify consistency among methods, we also calculated the intraclass correlation coefficient (method ICC [3, 1] of Shrout and Fleiss 10 ), using an analysis-of-variance procedure that modeled standardized mortality ratios as a function of method fixed effects and hospital random effects. This approach reflected two of our key assumptions: that only these four specific methods were of interest and that the discharges represented a sample of discharges that could change from year to year.
comparing estimates of hospital performance
Each method indicated whether a hospital was a mortality outlier in each of the 3 years. We compared how each hospital was categorized according to each of the methods into three mutually exclusive groups: higher-than-expected mortality, as-expected mortality, and lower-than-expected mortality. Typically, outlier designations were based on P values of 0.05 or 95% confidence intervals (see the Supplementary Appendix). However, the Dr. Foster method provided outlier designations on the basis of 3 years of data, along with annual standardized mortality ratios (including standard errors) for each hospital. To be consistent with other methods, we used Dr. Foster annual estimates and standard errors to identify hospitals with lower-than-expected, as-expected, or higher-than-expected mortality, with a P value of less than 0.05 indicating statistical significance. (The Dr. Foster method typically uses funnel charts with 99.8% control limits.) We quantified agreement between method pairs using kappa statistics and characterized the strength of agreement using the Landis and Koch approach. 11 R e sult s
Discharge and Hospital Cohorts
A total of 83 Massachusetts hospitals had 2,528,624 hospital discharges during the study period, with an overall in-hospital mortality rate of 2.1% (Table 1) . Two methods excluded some hospitals from their mortality calculations. Percentages of discharges that were included by each method ranged from 28% for UHC-Premier to 95% for 3M. Methods varied widely not only in the numbers of discharges analyzed but also in the distributions of included diagnoses. For example, discharges analyzed by UHC-Premier and Dr. Foster methods had overall in-hospital mortality rates of 5.9% and 4.0%, respectively, perhaps because these methods included higher proportions of patients with respiratory or cardiovascular diagnoses than did the other methods.
Discharge-Level Mortality
Of 2,528,624 total discharges, 567,784 (22%) were included in all four methods (Table 1 ). These 22% of discharges involved patients who were older and had higher in-hospital mortality, longer lengths of stay, and more respiratory and circulatory system diagnoses than patients in Massachusetts overall.
Individual discharge-level predicted probabilities of in-hospital death ranged from 0 to 0.999 among the four methods (data not shown). Pairwise associations of individual predicted probabilities for the 22% of discharges that were common among the four methods ranged from 0. Table 2 ). Estimated Pearson correlation coefficients were slightly lower among pairs when discharges that were common to each pair of methods were used rather than discharges that were common to all methods (data not shown).
Hospital-Level Mortality
The four methods produced different estimates of hospital-level mortality and assessments of whether individual hospitals had higher-than-expected or lower-than-expected mortality. Every method provided hospital-wide estimates for 77 of the 83 Massachusetts hospitals for discharges in fiscal year 2005, for 78 hospitals in fiscal year 2006, and for 75 hospitals in fiscal year 2007. Excluded hospitals were usually specialty facilities (e.g., rehabilitation hospitals). Pairwise correlations of hospital-wide standardized mortality ratios depended on the weighting of measures, ranging from 0.32 to 0.74 (Table 3) . UHC-Premier and 3M had the strongest linear correlations, regardless of the weighting method used. Using fiscal year 2007 data, Thomson Reuters produced an estimate for Hospital C, a large general hospital, that differed from the estimates with all the other methods ( Fig. 1) . The Thomson Reuters estimate was based on 3% of Hospital C's total discharges, whereas the other methods used more than 30% of the discharges. Patients who were included in the Thomson Reuters analysis of Hospital C had 2533 a higher percentage of diagnoses that are generally associated with an increased risk of death (e.g., respiratory disease, cancer, infectious disease, and injuries) than the state population overall. Conversely, diagnoses with a low risk of death (e.g., pregnancy and childbirth) were underrepresented in the Thomson Reuters cohort for Hospital C. The mortality rate among these 3% of discharges was 59.8%, which was substantially higher than Hospital C's overall mortality rate (2.2%). Percentages of hospitals that were assessed as having lower-than-expected or higherthan-expected mortality were high and varied among methods (Fig. 2) . For example, in fiscal year 2005, the Dr. Foster method designated 15 of 77 hospitals (19%) as having higher-than-expected hospital-wide mortality, as compared with 38 of 77 hospitals (49%) so designated by 3M.
Kappa statistics indicated poor-to-substantial agreement 11 between methods in classifying hospital mortality performance, depending on the year and method pairs. In fiscal year 2007, kappa statistics for agreement between methods in designating higher-than-expected outliers ranged from −0.04 (UHC-Premier and 3M) to 0.39 (Thomson Reuters and Dr. Foster). For some individual hospitals, categorizations varied widely and in some cases were completely discordant. For instance, in fiscal year 2006, of 28 hospitals designated as having higher-than-expected hospital-wide mortality by one method, 12 were simultaneously classified as having lower-than-expected mortality by other methods (6 by one method, 3 by two methods, and 3 by three methods).
Discussion
The goal of assessing hospital-wide mortality rates is to make inferences about the relative quality of care among hospitals. Proponents believe that hospital-wide mortality metrics provide useful warning flags about problems with the quality of inpatient care, aid consumers in choosing a hospital, and help provide a focus for hospital quality-improvement activities. [12] [13] [14] [15] [16] [17] [18] [19] In addition to parsimony, this single, overall measure of hospital performance has other potentially attractive features. In-hospital death is unambiguous, usually undesired, and tabulated accurately. Hospital-wide mortality encompasses wide-ranging diagnoses, perhaps providing more expansive insight than metrics that are based on single diagnoses. Hospital-wide results may uncover cross-cutting concerns, such as infection control, handoffs of patient care between shifts, and care coordination.
The four commercially available methods for assessing hospital-wide mortality that we studied are marketed to hospitals to support internal quality-improvement activities. However, their implications are even more important, and the corresponding need for methodologic accuracy is greater, when such measures are used for broader initiatives, such as public reporting or perfor- mance-based purchasing. We found that estimates of hospital-wide mortality could vary, sometimes widely, among methods, which consequently leads to different inferences regarding the quality of hospital care. Although these analyses used Massachusetts data, our results should be generalizable to other hospitalized populations. Explanations for these discrepancies are largely embedded within the different inclusion and exclusion criteria (for patients, diagnoses, and hospital types) among the four methods and in how each method analyzed hospital discharge abstract data to quantify in-hospital risks of death. These methodologic differences produced large differences in the patient cohorts that were evaluated by each approach, with only one fifth of discharges included among all methods. Thus, it is not surprising that different methods rated the same individual hospitals at either end of the spectrum of mortality categories (higher than expected vs. lower than expected). The observed differences in eligibility and exclusion criteria among methods may reflect the degree to which those who developed the methods were willing to accept uncertainty in the presumed association between mortality and hospital quality. With more liberal inclusion criteria, the analyses would probably include some diagnoses for which the linkages between in-hospital mortality and quality are problematic. In addition to differences in case-selection criteria, other methodologic differences ( Table 2 in the Supplementary Appendix) may also have contributed to the discrepant results of the four methods.
Differences in categorizing performance on the basis of hospital-wide mortality rates raise the inevitable question of which method best identifies potential quality problems. Our study could not address that question, since an observable benchmark for overall hospital quality does not exist. Without such a standard, our analytic approach relied on convergence, another indicator of validity (i.e., the extent of agreement among results obtained with different measurement methods 20, 21 ). If different methods ostensibly aim to capture the same construct (e.g., the quality of hospital care) and their results are similar, such convergence is reassuring. It is one piece of evidence that these methods provide valid information about that construct. In our study, hospitallevel results differed among methods, sometimes substantially, and in some instances, these differences would lead to completely divergent inferences. This disagreement suggests that all methods are not reflecting the same underlying construct, although it is possible that one method might perform better than the others in estimating the quality of hospital care. The substantial differences we observed among methods for estimating hospital-wide mortality are similar to the findings of a study 22 of condition-specific mortality rates and hospital performance. The aggregation of results from many disparate diagnoses is methodologically complex and may accentuate the magnitude of differences among methods.
A broader question is whether in-hospital mortality rates are valid quality indicators. [4] [5] [6] [23] [24] [25] [26] [27] [28] Studies have examined the relationships between hospital mortality rates for individual conditions and judgments about quality generated through medical-record reviews conducted by experienced clinicians. In general, the correlations have been poor. This finding may reflect the absence of an association between in-hospital mortality and quality or, given the study designs, the confounding effects of small samples and randomness, inadequate risk adjustment, coding problems, or other methodologic concerns. 22, 25, 26, [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] These issues are even more worrisome when it comes to hospital-wide mortality measures that encompass a diverse portfolio of conditions and procedures. For some diagnoses (e.g., major trauma or advanced cancer), linking in-hospital mortality with hospital quality is clearly problematic. Regardless of whether a palliative care or "do not resuscitate" (DNR) order is written, patients with such diagnoses still have a higher likelihood of dying than patients overall, even if a high quality of care is delivered. The four methods we examined used different criteria for identifying such patients and determining whether to include them in hospital-wide mortality estimates. Differences in hospital mortality findings among methods also probably relate to inadequacies of the data source (currently limited to administrative claims data for hospital-wide approaches) and the different accommodations for such problems among methods. For example, although Massachusetts discharge abstracts contain status codes for patients receiving palliative care and for those with DNR orders, individual hospitals report these markers inconsistently. The four methods varied in how they handled these indicators or whether they were considered at all. Although the inclusion of these factors makes clinical sense, a potential for "gaming" exists when risk-adjusted mortality rates are used for public reporting or determining reimbursement. 5 If quality problems occur during a patient's admission that increase the likelihood of death, hospitals might code such patients as having DNR orders or move them to palliative care status. Some observers have asserted that increased coding for palliative care might have accounted in part for an apparent temporal reduction in hospital-wide mortality rates in the United Kingdom. 5 The use of data on hospital discharge abstracts is also complicated by the difficulty in distinguishing intrinsic illnesses at the time of patients' admissions from complications that arise during their subsequent care. If risk-adjustment calculations misclassify complications as coexisting illnesses, this might mask the very quality problems that hospital-mortality metrics aim to identify. One potential solution is the recent requirement to add "present on admission" (POA) flags to discharge diagnoses. Massachusetts began requiring POA coding for all hospital discharges in fiscal year 2006. However, hospitals have been slow to report these POA indicators consistently, and the quality and accuracy of such indicators remain questionable. Although some fraction of our data set included POA indicators, this information was too inconsistent and inadequate to consider in these analyses -an important limitation of our study.
Despite these concerns, some individual hospital findings could be useful to potential consumers or to hospitals. In fiscal year 2006, all four methods identified three hospitals as having higher-than-expected mortality. In fiscal year 2007, all four methods identified one hospital as having lower-than-expected mortality and another hospital as having higher-than-expected mortality. Given this consistency, it is likely that these hospitals differ somehow from others, but we were unable to further investigate these findings. Furthermore, in real-world settings, agencies or hospitals are unlikely to use more than one method of mortality measurement. Since they typically must select a single method, opportunities for comparing results among methods -and therefore identifying consistently high or low outlier hospitals -are unavailable.
Notwithstanding differences in eligibility and exclusion criteria and in statistical methods, the substantially different results we observed among methods may reflect flaws in the fundamental hypothesis that hospital-wide mortality is a valid metric for the quality of hospital care. Our study also does not rule out the possibility that the estimation of hospital-wide mortality rates on the basis of nationally standardized eligibility and exclusion criteria with the use of fixed time intervals for end points (e.g., death within 30 days after admission) might produce more concordant results. However, the four modeling approaches were sufficiently dissimilar in other respects that greater agreement is by no means certain. If appropriate standards existed or were developed, evaluation of such an approach would be a logical next step.
Our results suggest that efforts to use hospital-wide mortality rates to evaluate the quality of care must proceed cautiously. At least among the four widely used and representative methods that we studied, different approaches to measurement produced different results, leading to different and sometimes completely discordant impressions about relative hospital performance. These issues will grow in urgency and importance as state and national mandates for developing and reporting hospital-quality metrics are implemented. One potential alternative to the use of hospital-wide mortality rates as a metric would be to estimate hospital quality on the basis of a more limited subgroup of diagnoses for which the link between mortality and quality is most plausible, sample sizes and end points are adequate, and credible risk models are available or can be developed.
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